MetaADEDB 2.0 @ LMMD
Benzydamine
(CNBGNNVCVSKAQZ-UHFFFAOYSA-N)
Structure
SMILES
CN(CCCOc1nn(c2c1cccc2)Cc1ccccc1)C
Type(s)
Approved
ATC code(s)
A01AD02; G02CC03; M01AX07; M02AA05; R02AX03
Molecular Formula:
C19H23N3O
Molecular Weight:
309.405
Log P:
3.4151
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
30.29
CAS Number(s):
132-69-4; 642-72-8
Synonym(s)
1.
Benzydamine
2.
Benzindamine
3.
Benzidamine
4.
Benzydamine Hydrochloride
5.
Benzydamine Monohydrochloride
6.
Difflam
7.
Lonol
8.
Novo-Benzydamine
9.
Opalgyne
10.
PMS-Benzydamine
11.
Ratio-Benzydamine
12.
Rosalgin
13.
Sun-Benz
14.
Tantum
15.
Tantum Topico
16.
Hydrochloride, Benzydamine
17.
Monohydrochloride, Benzydamine
18.
Novo Benzydamine
19.
PMS Benzydamine
20.
Ratio Benzydamine
21.
Sun Benz
External Link(s)
MeSHD001591
PubChem Compound12555
BindingDB50103598
50095471
ChEBI94563
CHEMBLCHEMBL12610
DrugBankDB09084
DrugCentral3881
KEGGdr:D07516
Therapeutic Target DatabaseD06FJO
ZINC2020083
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AgraphiaOFFSIDES
2Anal abscessOFFSIDES
3Antiphospholipid antibodies positiveOFFSIDES
4ApathyOFFSIDES
5Arteriosclerosis ObliteransOFFSIDES
6Arteriovenous graft thrombosisOFFSIDES
7ArthritisOFFSIDES
8Ataxia6031923CTD
9BlepharitisOFFSIDES
10Blood fibrinogen increasedOFFSIDES
11BronchopneumoniaOFFSIDES
12Cardiac TamponadeOFFSIDES
13Catheter related infectionOFFSIDES
14CellulitisOFFSIDES
15CholangiolitisOFFSIDES
16Diastolic dysfunctionOFFSIDES
17Diffuse alveolar damageOFFSIDES
18DrowsinessSIDER
19Drug Eruptions11792017CTD
20Drug ineffectiveCanada Vigilance: 2Canada Vigilance
21DuodenitisOFFSIDES
22Erythema MultiformeOFFSIDES
23General physical health deteriorationOFFSIDES
24Growth Disorders6031923CTD
25HeadacheSIDER
26Impaired self-careOFFSIDES
27Kidney Diseases8298379CTD
28Large intestine perforationOFFSIDES
29LaryngospasmOFFSIDES
30LethargyOFFSIDES
31Limb operationOFFSIDES
32Lung consolidationOFFSIDES
33Metastatic Renal Cell CarcinomaOFFSIDES
34MononeuritisOFFSIDES
35Muscle hypotonia6031923CTD
36Musculoskeletal chest painOFFSIDES
37NauseaSIDER
38Neutropenic colitisOFFSIDES
39Neutropenic sepsisOFFSIDES
40NumbnessSIDER
41PainSIDER
42PeritonitisOFFSIDES
43Peritonsillar AbscessOFFSIDES
44Product quality issueCanada Vigilance: 1Canada Vigilance
45Pseudomonal sepsisOFFSIDES
46Seizures6031923CTD
47Sialorrhea6031923CTD
48SinusitisOFFSIDES
49Skin lacerationOFFSIDES
50SomnolenceSIDER
51Tachycardia6031923CTD
52Temporal ArteritisOFFSIDES
53ThirstSIDER
54Throat irritationSIDER
55TonsillitisOFFSIDES
56Urticaria11792017CTD
57Ventricle ruptureOFFSIDES
58Vomiting6031923CTD
SIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.